3 withdrawn. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Withdrawn 3 |
| Phase 3 | 1 | Withdrawn 1 |
Follow Hypopigmentation: new trials by email Literature Review of Hypopigmentation trials Research Report on Hypopigmentation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating the Efficacy and Safety of Metformin in Vitiligo Metformin Hydrochloride - Vitiligo | Phase 2 | Withdrawn | University of Massachusetts, Worcester | 2025-07-01 | 2024-09-24 | |
| Comparative Study of Techniques in Melanocyte-Keratinocyte Transplantation for the Treatment of Vitiligo Melanocyte Keratinocyte transplantation - Vitiligo | Phase 2 / Phase 3 | Withdrawn | Henry Ford Health System | 2010-05-01 | 2017-03-10 | |
| Medical Treatment of Colitis in Patients With Hermansky-Pudlak Syndrome Mesalamine, Infliximab, Corticosteroids - Hermanski-Pudlak Syndrome, Colitis | Phase 2 | Withdrawn | National Institute of Allergy and Infectious Diseases (NIAID) | 2007-08-07 | 2017-07-02 |
Vitiligo (2) · Colitis (1) · Hermanski-Pudlak Syndrome (1)
Pigmentation Disorders (3) · Skin Diseases (3) · Skin and Connective Tissue Diseases (3) · Albinism (1) · Albinism, Oculocutaneous (1) · Amino Acid Metabolism, Inborn Errors (1) · Blood Coagulation Disorders (1) · Blood Coagulation Disorders, Inherited (1) · Blood Platelet Disorders (1) · Colonic Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Digestive System Diseases (1) · Eye Diseases (1) · Eye Diseases, Hereditary (1)
Adalimumab (1) · Adrenal Cortex Hormones (1) · Infliximab (1) · Mercaptopurine (1) · Mesalamine (1) · Metformin (1) · Tacrolimus (1)
Henry Ford Health System (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · University of Massachusetts, Worcester (1)
United States (3)
Iltefat H Hamzavi, MD (1) · John E Harris, MD, PhD (1)